학술논문
Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events
Document Type
Article
Author
Source
In: PLoS ONE . (PLoS ONE, April 2022, 17(4 April))
Subject
Language
English
ISSN
19326203